Clinical Trial Update: Effects of Teriparatide in Postmenopausal Women With Osteoporosis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing the effects of teriparatide in postmenopausal osteoporosis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• Forteo (teriparatide)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Postmenopausal Osteoporosis | Phase 4 | Status: COMPLETED